ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1428	National Cancer Institute	Html	null	Retinoblastoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of retinoblastoma in children.			CLICK HERE
1544	National Cancer Institute	Html	en	Adult Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adult acute myeloid leukemia.	adult aml 0.716289 red blood cells 0.594071 cancer treatment 0.467513 blood -forming cells 0.4491 acute myeloblastic leukemia 0.44585 acute myelogenous leukemia 0.445245 chemotherapy 0.473847 PDQ cancer information 0.503817 white blood cells 0.675945 clinical trials 0.938073 mature blood cells 0.50039 cancer information summary 0.459101 clinical trial 0.615294 stem cells 0.519631 stem cell transplant 0.480735 acute granulocytic leukemia 0.446114 Myeloid Leukemia Treatment 0.448761 blood cells 0.735668 radiation therapy 0.468603 treatment 0.673705 myeloid stem cell 0.438755 stored stem cells 0.437216 immature blood cells 0.448693 arsenic trioxide 0.473356	cancer cells 0.602593 specific cancer cells 0.456728 recurrent adult aml 0.474546 untreated adult aml 0.465491 acute myeloid leukemia 0.930922 stem cell 0.533281 treatment clinical trials 0.44329 blood stem cells 0.488116 National Cancer Institute 0.460343 spinal cord 0.512703 normal cells 0.467456 myeloid stem cells 0.482174 new treatment 0.480473 white blood cell 0.463646 combination chemotherapy 0.472241 bone marrow 0.747056 cells 0.827248 acute promyelocytic leukemia 0.5928 cancer clinical trials 0.452604 acute nonlymphocytic leukemia 0.445812 acute lymphoblastic leukemia 0.434651 acute leukemia 0.43925 cancer 0.808047 standard treatment 0.467846	CLICK HERE
1657	National Cancer Institute	Html	en	Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood medulloblastoma, nonmedulloblastoma embryonal tumors, and pineal tumors.	adjuvant chemotherapy 0.284178 primitive neuroectodermal tumors 0.441731 Low-stage medulloblastoma 0.276631 standard risk medulloblastoma 0.295812 craniospinal radiation therapy 0.289613 prognostic factors 0.298331 chemotherapy 0.308667 high-risk disseminated medulloblastoma 0.295264 medulloblastoma extent 0.319739 metastatic medulloblastoma 0.292959 early childhood medulloblastoma 0.501191 brain tumors 0.331694 children 0.47617 von Bueren AO 0.264775 young children 0.341987 Cancer Group 0.327468 Radiat Oncol Biol 0.296868 WNT medulloblastoma cases 0.313174 medulloblastoma 0.767685 nonmedulloblastoma embryonal tumors 0.263341 medulloblastoma subgroups 0.365378 paediatric medulloblastoma 0.27996 von Hoff 0.292117 desmoplastic/nodular medulloblastoma 0.301127 desmoplastic medulloblastoma 0.355762	syndrome-associated childhood medulloblastoma 0.323686 medulloblastoma patients 0.341131 Clin Cancer Res 0.271749 radiation therapy 0.321079 Acta Neuropathol 0.331155 et al. 0.786797 Pediatr Blood Cancer 0.60557 pineal gland cyst 0.276571 medulloblastoma resection 0.293465 standard-risk medulloblastoma 0.318484 average-risk medulloblastoma 0.337894 Medulloblastoma variants 0.320092 Abstract 0.770373 Clin Oncol 0.950195 pediatric medulloblastoma 0.392703 Oncol Biol Phys 0.298432 embryonal tumors 0.349688 medulloblastoma resections 0.29489 nonmetastatic medulloblastoma 0.294586 embryonal brain tumors 0.299215 newly diagnosed medulloblastoma 0.289358 medulloblastoma subtypes 0.331966 complexity underlying medulloblastoma 0.308738 WNT medulloblastoma tumors 0.354112	CLICK HERE
1854	National Cancer Institute	Html	es	Tratamiento del melanoma ocular uveal (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del melanoma ocular uveal.	Lippincott Williams 0.0202121 Compton CC 0.0326793 intraocular melanoma 0.187253 Singh AD 0.0183835 mortality findings 0.0177193 initial mortality findings 0.0168176 Collaborative Ocular Melanoma 0.845271 tumores coroideos 0.0533438 concerning uveal melanomas 0.0413676 transformation into melanoma 0.0471527 7th ed 0.0334776 melanoma intraocular uveal 0.0617166 transpupillary thermotherapy 0.0364759 choroidal melanoma 0.885011 Ophthalmol Clin 0.0328664 melanoma coroideo 0.351056 Radiat Oncol Biol 0.049169 DeVita VT Jr 0.0170972 coms report 0.12083 Iris melanomas 0.0424181 choroidal melanoma ii 0.0483613 small choroidal melanoma 0.146057 from intraocular melanoma 0.0447667 metastatic melanoma 0.0397711 Ocular Melanoma Study 0.837498	Shields JA 0.126368 Diffuse choroidal melanoma 0.048527 COMS randomized 0.0359843 melanomas coroideos 0.0974806 uveal melanomas 0.9898 Melanoma Study Group 0.158608 Malignant melanoma 0.12436 from uveal melanoma 0.0570651 Cancer Staging Manual 0.0611746 uveal melanoma management 0.0496842 COMS Medium Tumor 0.0243028 Arch Ophthalmol 0.4179 large choroidal melanoma 0.0789386 New York 0.0440447 cLos melanomas 0.0368816 Diener-West M 0.0182158 large uveal melanomas 0.0943176 Oncol Biol Phys 0.0503576 malignant uveal melanoma 0.051425 unrecognized choroidal melanoma 0.0480539 Byrd DR 0.0304967 Shields CL 0.154709 Int Ophthalmol Clin 0.0287474 AJCC Cancer Staging 0.0646958	CLICK HERE
1869	National Cancer Institute	Html	es	Tratamiento del sarcoma de tejido blando infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando infantil.	Pediatric Oncology 0.427738 Childhood soft tissue 0.412657 Sarcoma Group 0.408529 soft part sarcoma 0.421702 Pediatr Surg Int 0.410488 tumor >5 cm 0.40873 Neonatal soft tissue 0.41137 pediatric nonrhabdomyosarcoma soft 0.423413 soft-tissue sarcoma 0.42357 oncology group study 0.42018 sarcoma necessary after 0.409292 Children's Oncology Group 0.423153 sarcoma results 0.408962 undifferentiated sarcoma 0.409416 5th ed 0.408863 pediatric soft tissue 0.468096 Weiss's Soft Tissue 0.465072 soft tissue sarcoma 0.984779 low-grade fibromyxoid sarcoma 0.417727 Jude Children Research 0.411214 lower extremity sarcomas 0.408827 nonrhabdomyosarcoma soft 0.450499 sarcoma patients 0.409132 End Results 0.409463 Surg Pathol 0.410619	cuello sarcoma 0.408715 Ferrari A 0.410275 Pediatr Blood Cancer 0.449691 Cancer Staging Manual 0.440273 Weiss SW 0.438749 Genes Chromosomes Cancer 0.409368 Translocation-related sarcomas 0.408627 Surg Oncol 0.422483 Adult-type soft tissue 0.411539 Sarcomas embrionarios 0.408595 Pediatr Surg 0.44479 part sarcoma fuses 0.409332 Clin Oncol 0.434253 Children's Research Hospital 0.410798 Goldblum JR 0.438633 sarcomas with surgery 0.409572 soft tissue tumors 0.508399 Pediatric Oncology Group 0.420884 >5 cm 0.415115 retroperitoneo sarcoma 0.408795 round cell tumor 0.41657 Oncology Group 0.440064 localized soft-tissue sarcomas 0.40921 AJCC Cancer Staging 0.461396	CLICK HERE
1872	National Cancer Institute	Html	es	Tratamiento del cáncer de células de transición de pelvis renal y de uréter (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de células de transición de pelvis renal y de uréter.	Compton CC 0.310067 prognostic factors 0.311079 Roth BJ 0.353197 transitional cell carcinoma 0.558604 Sin embargo 0.332107 Ta Carcinoma 0.313126 Elson PJ 0.309122 California Oncology Group 0.314515 7th ed 0.310032 tumores renales 0.309511 pelvis renal 0.960657 Instituto Nacional 0.312591 metástasis distantes 0.32208 células transicionales recidivantes 0.361913 pared pélvica renal 0.316324 parénquima renal t3 0.317938 cooperative group study 0.316918 Cooperative Oncology Group 0.315511 tejido renal 0.313083 metastatic transitional cell 0.319135 preliminary report from 0.31524 group study 0.325781 Einhorn LH 0.327583 urinary tract 0.331593 función renal 0.325386	Northern California Oncology 0.31495 upper urinary tract 0.318654 effective chemotherapy regimen 0.317306 Oncology Group study 0.317114 Nocks BN 0.30983 Cancer Staging Manual 0.321607 PDQ Tratamiento 0.309071 Renal pelvic tumors 0.315825 New York 0.30907 Daly JJ 0.308968 with paclitaxel 0.310585 Clin Oncol 0.437926 parénquima renal 0.327814 Byrd DR 0.309554 urothelial carcinoma 0.398878 gallium combination chemotherapy 0.316792 insuficiencia renal 0.313531 Eastern Cooperative Oncology 0.315974 renal pelvis 0.422209 Oncology Group 0.324511 Tis Carcinoma 0.313191 metastatic urothelial carcinoma 0.363244 AJCC Cancer Staging 0.322547 Edge SB 0.31008	CLICK HERE
1953	National Cancer Institute	Html	es	Efectos tardíos del tratamiento anticanceroso en la niñez (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de los problemas de salud que continúan o aparecen después de terminar un tratamiento de cáncer.	válvulas cardíacas 0.300344 digestivasLos efectos tardíos 0.301994 siguientes procedimientos 0.300445 células madre 0.31868 suficiente saliva 0.300202 adultos jóvenes 0.300215 tumor tipo 0.3006 leucemia linfocítica aguda 0.300977 leucemia linfoblástica aguda 0.303718 diabetes mellitus 0.300401 rayos x 0.300187 largo plazo 0.301433 alta densidad 0.300367 debilidad súbitos 0.300398 efectos tardíos 0.995697 luz solar 0.30049 tumores benignos 0.300573	siguientes maneras 0.300324 hormonas tiroideas 0.300415 antecedentes familiares 0.302575 revestimiento protector 0.300332 hepatitis b 0.300262 siguientes factores 0.300516 radiación uv 0.300991 topoisomerasa ii 0.300497 suficiente insulina 0.300239 cuerpo elabora insulina 0.300315 Radiografía panorámica 0.300213 leucemia mieloide aguda 0.302575 mandíbulasLos problemas 0.300385 cáncer infantil meses 0.303991 biliaresLos efectos tardíos 0.30194 Mayor tiempo 0.300312 siguientes pruebas 0.300654	CLICK HERE
1986	National Cancer Institute	Html	es	Linfedema (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre la anatomía, la patofisiología, las manifestaciones clínicas, el diagnóstico y el tratamiento del linfedema relacionado con el cáncer, una afección en la que se acumula líquido linfático en los tejidos y causa inflamación..	after sentinel lymph 0.313822 Ridner SH 0.344357 group trial 0.315465 Sin embargo 0.344649 upper extremity lymphedema 0.331183 linfedema usa 0.380409 controlled trial with 0.318641 CA Cancer 0.317513 ganglios linfáticos centinelas 0.349529 arm lymphedema after 0.317881 extremity lymphedema after 0.335236 Cancer statistics 0.316994 treatment-related lymphedema 0.324253 lymphedema after breast 0.383555 ganglio centinela 0.352856 axillary sampling with 0.313496 conductos linfáticos subclavios 0.335825 Petrek JA 0.323456 Schmitz KH 0.339884 Sport Sci Rev 0.321461 controlled trial comparing 0.313482 randomized controlled 0.341872 Balancing lymphedema risk 0.334354 breast cancer-related lymphedema 0.386776 tronco linfático subclavio 0.332389	arm lymphedema 0.323652 axillary dissection with 0.315734 vena subclavia 0.3286 Care Cancer 0.334426 exercise versus deconditioning 0.326793 with axillary lymph 0.315505 ganglio linfático centinela 0.380935 with arm lymphedema 0.319809 Arch Phys Med 0.320628 discrepancia intramiembro 0.359416 Phys Med Rehabil 0.321125 breast carcinoma survivors 0.322235 lower-extremity lymphedema secondary 0.313534 with breast-cancer-related lymphedema 0.31752 Ahmed RL 0.322704 Clin Oncol 0.373772 breast cancer 0.91318 sentinel lymph 0.326667 Breast Cancer Study 0.332383 with or without 0.326647 Exerc Sport Sci 0.322466 axillary lymph 0.328084 Weight lifting 0.32136 Breast Cancer Res 0.331771	CLICK HERE
2066	National Cancer Institute	Html	es	Los cuidados al final de la vida de personas con cáncer	Hoja informativa que responde algunas de las preguntas que tienen muchos pacientes, sus familiares y quienes cuidan de ellos acerca del final de la vida.	desechos quizás 0.586339 pequeñas porciones 0.540804 alcance objetos 0.559532 suficientes glóbulos 0.562578 causa hinchazón 0.558057 dosis correctos 0.546349 médicos cuánto tiempo 0.63336 suficiente oxígeno 0.652738 cuánto tiempo 0.903324 suficiente tejido 0.550065 paciente experimenta síntomas 0.986626 paciente quizás 0.789052 considerable agitación 0.540843 quizás querrán 0.579319	menor flujo 0.542617 presente somnolencia 0.544492 reducida capacidad 0.540414 persona enferma causa 0.731054 malos días 0.539357 mejores cuidadores 0.583437 Mayor debilidad 0.544974 falsas esperanzas 0.572246 siguientes situaciones 0.566454 cuerpo boca 0.542456 familia esté lista 0.658292 paciente presente incontinencia 0.756496 persona quizás 0.668635	CLICK HERE
3455	National Cancer Institute	Html	es	Acupuntura (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre la acupuntura como tratamiento para las personas con cáncer o trastornos relacionados con esta enfermedad.	Zhang G 0.32606 chinese herbs 0.319163 Niemtzow RC 0.320654 Ghaly RG 0.32227 cáncer gástrico grupo 0.319634 splenic natural killer 0.318671 consecutivos dolor 0.340228 acupuntura versus 0.39936 Pharmacol Biochem Behav 0.321201 Yang J 0.320136 cáncer grupo 0.365962 ECA Dolor 0.328485 Chinese Acupuncture 0.324024 traditional chinese 0.334765 Estados Unidos 0.464193 Oriental Medicine 0.333741 Zhongguo Zhong Xi 0.337599 its regulative function 0.324075 Med Hist 0.316569 Mod Med Asia 0.316861 Zhong Xi Yi 0.336593 Pain Symptom Manage 0.370153 Xi Yi Jie 0.336643 Altern Complement Med 0.372332 Complement Ther Med 0.320059	Hand Acupuncture Therapy 0.319232 killer cell cytotoxicity 0.32019 Acupuncture techniques 0.319086 Curr Probl Cancer 0.317979 acupuntura guanyuan 0.365152 Tradit Chin Med 0.903597 alternative medicine 0.411597 Churchill Livingstone 0.334944 Dundee JW 0.395667 New York 0.354273 Soc Med 0.364691 systematic review 0.333425 cáncer óseo 0.319179 Zhang RX 0.320688 Acupuncture stimulation enhances 0.344465 acupuntura mejora 0.364667 treated with 0.328504 Desconocida Sí 0.317149 chinese medicine 0.449414 Za Zhi 0.321785 Acupuncture prophylaxis 0.318487 Liu B 0.317806 stimulation enhances splenic 0.322832 Fitzpatrick KT 0.320501	CLICK HERE